Clozapine-induced reversible Brugada Syndrome

DOI: 10.5176/2382-5669_CCMR14.15

Authors: Dr Jun Hua Chong and Dr Franz Eversheim

Abstract:

We describe a case of reversible Brugada Syndrome in a patient on Clozapine for schizophrenia, highlighting the risk of antipsychotics causing a variety of phenotypic expressions of predisposing sodium channelopathy.

Keywords: Clozapine; Brugada Syndrome; Sodium channelopathy; Antipsychotics